Health

ActLight: Ultra Small, Very Low Power Consumption Heart Rate Monitoring Sensor for Hearables? You Need the ActLight Dynamic Photodiode

LAUSANNE, Switzerland, Nov. 25, 2019 /PRNewswire/ -- Long battery life, precision of measurements and very small size are the key requirements for vital signs monitoring sensors in hearable devices. The Dynamic PhotoDiod...

2019-11-25 08:19 2193

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

SINGAPORE, Nov. 25, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-25 08:15 2178

Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference

SYDNEY, Nov. 25, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share with investors interim data from its ongoing phase II study of GDC-0084 in glioblastoma, the most common and most aggressive form of...

2019-11-25 07:00 2135

CPC Indonesia Design Week Concludes with Local Endorsement

MAKASSAR, Indonesia, Nov. 23, 2019 /PRNewswire/ -- The International Water, Sanitation and Hygiene Foundation's (IWSH) Community Plumbing Challenge (CPC) program has completed its latest installment, a Design Week project in the coastal village of Kampung Nelayan Untia. An intensive four-day ass...

2019-11-23 04:01 1988

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 5577

Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China

BEIJING, Nov. 22, 2019 /PRNewswire/ -- China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO") has successfully completed patient enrollment of the Phase III study of Adapalene-Clindamycin Combin...

2019-11-22 23:50 3487

Guardant Health AMEA wins this year's Growth Excellence Leadership Award by Frost & Sullivan

SINGAPORE, Nov. 22, 2019 /PRNewswire/ -- Guardant Health AMEA has won Frost & Sullivan's Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. "We are delighted to receive this prestigious award from Frost & Sullivan. T...

2019-11-22 15:37 1689
1 ... 576577578579580